Filing Flows › Guardian Pharmacy Services (GRDN) › Q3 2026 › vs Q2 2026
Guardian Pharmacy Services (GRDN) Q3 2026 vs Q2 2026 (quarter over quarter)
Guardian Pharmacy Services's revenue rose $19.3M (+5%) from $352M in Q2 2026 to $371M in Q3 2026. Gross margin 23.0% against 22.8% (+0.2 pts).
Guardian Pharmacy Services, Q3 2026: revenue $371M (-2% year over year), operating margin 6.8%, net earnings $18.7M, operating cash flow $43.4M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 23.0% | 22.8% | +0.2 pts |
| Operating margin | 6.8% | 5.9% | +0.9 pts |
| Net margin | 5.0% | 6.2% | -1.2 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $371M | $352M | $19.3M | +5% |
| Gross profit | $85.2M | $80.0M | $5.2M | +6% |
| Cost of revenue | $286M | $272M | $14.1M | +5% |
| Operating profit | $25.1M | $20.6M | $4.4M | +21% |
| Operating expenses | $60.2M | $59.4M | $760K | +1% |
| Pre-tax earnings | $26.0M | $29.8M | −$3.8M | -13% |
| Net earnings | $18.7M | $21.9M | −$3.2M | -15% |
| Minority interests | $440K | $249K | $191K | +77% |
| Income tax | $6.9M | $7.7M | −$814K | -11% |
| Depreciation & amortization | $5.9M | $5.8M | $124K | +2% |
| Share-based compensation | $2.7M | $2.9M | −$197K | -7% |
| Working capital & other | $16.0M | −$587K | $16.6M | — |
| Operating cash flow | $43.4M | $30.0M | $13.3M | +44% |
Questions
How much did Guardian Pharmacy Services's revenue grow quarter over quarter in Q3 2026?
Guardian Pharmacy Services's revenue rose $19.3M (+5%) from $352M in Q2 2026 to $371M in Q3 2026. Gross margin 23.0% against 22.8% (+0.2 pts).